Inverness Counsel’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $562K | Buy |
1,739
+51
| +3% | +$16.5K | 0.03% | 116 |
|
|
2022
Q2 | $547K | Sell |
1,688
-80
| -5% | -$25.9K | 0.03% | 114 |
|
|
2022
Q1 | $506K | Buy |
1,768
+12
| +0.7% | +$3.43K | 0.02% | 124 |
|
|
2021
Q4 | $485K | Sell |
1,756
-12
| -0.7% | -$3.31K | 0.02% | 122 |
|
|
2021
Q3 | $408K | Buy |
1,768
+12
| +0.7% | +$2.77K | 0.02% | 134 |
|
|
2021
Q2 | $403K | Hold |
1,756
| – | – | 0.01% | 126 |
|
|
2021
Q1 | $328K | Sell |
1,756
-200
| -10% | -$37.4K | 0.01% | 124 |
|
|
2020
Q4 | $330K | Hold |
1,956
| – | – | 0.01% | 116 |
|
|
2020
Q3 | $290K | Hold |
1,956
| – | – | 0.01% | 115 |
|
|
2020
Q2 | $321K | Sell |
1,956
-174
| -8% | -$28.6K | 0.02% | 103 |
|
|
2020
Q1 | $295K | Hold |
2,130
| – | – | 0.02% | 99 |
|
|
2019
Q4 | $280K | Hold |
2,130
| – | – | 0.01% | 105 |
|
|
2019
Q3 | $238K | Sell |
2,130
-1,265
| -37% | -$141K | 0.01% | 108 |
|
|
2019
Q2 | $376K | Sell |
3,395
-475
| -12% | -$52.6K | 0.02% | 87 |
|
|
2019
Q1 | $502K | Sell |
3,870
-26,040
| -87% | -$3.38M | 0.03% | 80 |
|
|
2018
Q4 | $3.46M | Buy |
29,910
+27,255
| +1,027% | +$3.15M | 0.23% | 53 |
|
|
2018
Q3 | $285K | Buy |
2,655
+309
| +13% | +$33.2K | 0.02% | 112 |
|
|
2018
Q2 | $200K | Buy |
+2,346
| New | +$200K | 0.01% | 125 |
|